Skip to main content

Table 1 Clinicopathologic features of patients with different chemotherapy regimens

From: Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?

  No-chemo 5-FU Oxaliplatin
Gender    
  Male 448 321 131
  Female 324 219 92
Age at diagnosis, years    
  66-70 201 184 105
  71-75 234 175 70
  >75 337 181 48
Residence location    
  Big Metro 383 261 127
  Metro or Urban 303 199 77
  Less Urban or Rural 86 80 19
Year of diagnosis    
  1992-1996 17 10 0
  1997-2000 132 115 0
  2001-2004 296 251 26
  2005-2008 327 164 197
Histologic grade    
  Well 59 35 14
  Moderate 519 360 146
  Poor/Undifferentiated 116 87 37
  Unknown 78 58 26
ypT category    
  ypT1-2 261 146 50
  ypT3 446 367 160
  ypT4 65 27 13
ypN category    
  ypN0 609 339 134
  ypN1a 79 85 34
  ypN1b 42 59 26
  ypN2a 20 36 16
  ypN2b 22 21 13
ypTNM stage    
  ypTNM I 233 113 36
  ypTNM II 376 226 98
  ypTNM III 163 201 89
Intestinal obstruction    
  No 677 484 201
  Yes 95 56 22
HCC risk score    
  1st quartile 210 143 56
  2nd quartile 157 131 45
  3rd quartile 189 152 67
  4th quartile 216 114 55
Number of examined lymph node    
  ≥12 265 200 106
  <12 507 340 117
Postoperative radiotherapy    
  No 676 455 208
  Yes 96 85 15
  1. Abbreviations: HCC Hierarchical Condition Categories, No-chemo without postoperative chemotherapy, 5-FU 5-fluorouracil.
\